Switch to:
More From Other Websites
Today's Research Reports on Stocks to Watch: Geron and Galena Biopharma Mar 20 2017
Geron Corp. :GERN-US: Earnings Analysis: Q4, 2016 By the Numbers : March 17, 2017 Mar 17 2017
Geron Corp. :GERN-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017 Mar 15 2017
Geron Corp. breached its 50 day moving average in a Bearish Manner : GERN-US : March 15, 2017 Mar 15 2017
GERON CORP Financials Mar 07 2017
Edited Transcript of GERN earnings conference call or presentation 1-Mar-17 9:30pm GMT Mar 03 2017
GERON CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits Mar 03 2017
Geron Announces Presentation at American Association for Cancer Research Annual Meeting Mar 02 2017
GERON CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Mar 01 2017
Geron Corporation Reports Fourth Quarter and Annual 2016 Financial Results Mar 01 2017
GERON CORP Files SEC form 10-K, Annual Report Mar 01 2017
Q4 2016 Geron Corp Earnings Release - After Market Close Mar 01 2017
Geron Announces Conference Call to Discuss Fourth Quarter and Annual 2016 Financial Results Feb 22 2017
GERON CORP Files SEC form 8-K, Change in Directors or Principal Officers Feb 10 2017
Geron Corp. breached its 50 day moving average in a Bearish Manner : GERN-US : January 12, 2017 Jan 12 2017
Biotech Industry Off to a Strong Start in 2017 Latest Reports on Halozyme Therapeutics and Geron Jan 09 2017
GERON CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... Jan 09 2017
ETFs with exposure to Geron Corp. : December 29, 2016 Dec 29 2016
Geron Corp. breached its 50 day moving average in a Bullish Manner : GERN-US : December 26, 2016 Dec 26 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK